Joo-youn Lee
Daejeon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Discovery and Pharmacological Characterization of a Dual-Acting 2-Amino-3-Cyanopyridine Inhibitor Targeting Microtubule Polymerization and GAK.
Journal: Journal of medicinal chemistry
Published: June 16, 2026
Discovery of a New Tetrahydroquinoline-Based Chemotype for STING Inhibition with In Vivo Efficacy against Acute Kidney Injury.
Journal: Journal of medicinal chemistry
Published: April 18, 2026
Predicted molecules followed by experimental validation for protecting human neurons from oxidative stress-induced cytotoxicity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 03, 2025
Development and Evaluation of 1‑Hydroxypyridin-2(1H)‑one Derivatives as Antibacterial Agents against Pathogenic Pseudomonas aeruginosa.
Journal: ACS medicinal chemistry letters
Published: September 19, 2025
2-amido-3-aryl-4-methyl-thiazole derivatives as broad-spectrum anti-rhinoviral agents.
Journal: European journal of medicinal chemistry
Published: September 09, 2025
Critical amino acid residues in human ACE2 for SARS-CoV-2 spike protein binding and virus entry.
Journal: Microbiology spectrum
Published: June 20, 2025
Discovery of a selective dual-specificity tyrosine phosphorylation-regulated kinase 1B inhibitor with anti-adipogenic and anti-diabetic activities.
Journal: Frontiers in pharmacology
Published: June 11, 2025
Discovery of novel WRN inhibitors for treating MSI-H colorectal cancers.
Journal: Bioorganic & medicinal chemistry letters
Published: January 06, 2025
Blocking S1P4 signaling attenuates brain injury in mice with ischemic stroke.
Journal: Journal of advanced research
Published: September 29, 2024
Edeine B1 produced by Brevibacillus brevis reduces the virulence of a plant pathogenic fungus by inhibiting mitochondrial respiration.
Journal: mBio
Published: June 11, 2024
Correction: Highly potent and selective phosphatidylinositol 4-kinase IIIβ inhibitors as broad-spectrum anti-rhinoviral agents.
Journal: RSC medicinal chemistry
Published: May 21, 2024
7-Amino-3-phenyl-2-methyl-pyrazolopyrimidine derivatives inhibit human rhinovirus replication.
Journal: European journal of medicinal chemistry
Published: May 14, 2024
Last Updated: 09/26/2026